Pneumococcal vaccine does not appear to protect against pneumonia

Jan 05, 2009

Commonly used pneumococcal polysaccharide vaccines do not appear to be effective for preventing pneumonia, found a study by a team of researchers from Switzerland and the United Kingdom.

In many industrialized countries, polysaccharide pneumococcal vaccines (PPVs) are currently recommended to help prevent pneumococcal disease in people aged 65 and over and for younger people with increased risk due to conditions like HIV. Studies have shown conflicting results regarding the efficacy of PPV.

The study, a systematic review and meta-analysis, looked at 22 clinical trials, reviews and meta-analyses and more than 100,000 participants from countries in North America as well as India, Africa, Latin America and the Caribbean. Unlike other similar studies the authors examined the reasons why different clinical trials produced different results. They found that the quality of the studies substantially affected the results. When only high quality trials were included, there was no evidence that PPVs could prevent pneumonia. The study adds to the ongoing debate around effectiveness of the vaccine.

"Policy makers may therefore wish to reconsider their current recommendations for PPV, especially where routine pneumococcal conjugate immunization has been introduced," conclude Dr. Matthias Egger from the University of Bern, Switzerland and coauthors.

However, in a related commentary www.cmaj.ca/press/pg18.pdf, Dr. Ross Andrews and coauthor from the Menzies School of Health Research, Darwin, Australia state that the researchers' conclusions exceed the evidence presented. They caution that there should be no change in vaccine policy in countries that recommend PPV to prevent invasive pneumococcal disease.

Paper: www.cmaj.ca/press/pg48.pdf

Source: Canadian Medical Association Journal

Explore further: Supercomputers link proteins to drug side effects

add to favorites email to friend print save as pdf

Related Stories

Detecting and preventing disease in trout

Oct 06, 2014

Each year, the rainbow trout industry suffers significant economic losses due to bacterial cold-water disease, caused by the bacterium Flavobacterium psychrophilum. The disease also affects salmon and other ...

Winemaking taint smoked out

Sep 30, 2014

Winemaking methods influence the degree of smoke taint in wines made from smoke-exposed grapes, new research suggests.

Wireless sensor transmits tumor pressure

Sep 20, 2014

The interstitial pressure inside a tumor is often remarkably high compared to normal tissues and is thought to impede the delivery of chemotherapeutic agents as well as decrease the effectiveness of radiation ...

Google contest finalist at 14 has way out of cyberbullying

Aug 08, 2014

A 14 year-old student selected as a Google Science Fair 2014 finalist has come up with a Rethink project that asks teenagers to reread hurtful messages before sending them off and having to deal with consequences ...

Plant life considered in ecosystem synergies

Sep 12, 2014

Local flora species involved in UWA's Ridgefield Multiple Ecosystem Services Experiment are helping researchers to better understand agricultural processes including efficient nutrient cycles and maintaining ...

Recommended for you

Supercomputers link proteins to drug side effects

13 hours ago

New medications created by pharmaceutical companies have helped millions of Americans alleviate pain and suffering from their medical conditions. However, the drug creation process often misses many side ...

No added benefit proven for umeclidinium/vilanterol in COPD

20 hours ago

The drug combination umeclidinium/vilanterol (trade name Anoro) has been approved since May 2014 for adults with chronic obstructive pulmonary disease (COPD). In an early benefit assessment pursuant to the Act on the Reform ...

User comments : 0